EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

NCT04669002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: EP0057
DRUG: Olaparib tablets

Sponsor

Ellipses Pharma